FDA Approved: EZETIMIBE — Original Application (ScieGen Pharmaceuticals Inc)

View source ↗

Summary

FDA approved ScieGen Pharmaceuticals' original (ANDA) application for ezetimibe as a generic cholesterol-lowering medication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Cardiovascular Disease
• Familial Hypercholesterolemia
• Hypercholesterolemia
• Hyperlipidemia

Drugs mentioned

• EZETIMIBE (EZETIMIBE)

Snippet

ORIG AP for EZETIMIBE (EZETIMIBE)